LENZ Therapeutics LENZ
NASDAQ LENZ
$3.63 -0.16 (-4.23%)
As of: Oct 2, 2026 · 11:43 AM EDT

LENZ Therapeutics (LENZ) Return on Assets [ROA] (2021 - 2026)

Updated

LENZ Therapeutics (LENZ) posted Return on Assets [ROA] of -49.50% for Q2 2026, down 24.47 percentage points from -25.03% a year earlier and down 11.81 percentage points from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, LENZ Therapeutics' Return on Assets [ROA] came in at -31.52%, up 3.33 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a four-year change of +1.82 percentage points (FY2021 to FY2025).
  • In prior years, LENZ Therapeutics' Return on Assets [ROA] was -34.84% in FY2024 (+28.18 pp), -63.02% in FY2023 (-34.81 pp), -28.21% in FY2022 (+5.13 pp) and -33.33% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] since Q1 2024.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last four quarters, with an average year-over-year change of +10.76 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 57.41 percentage points; the weakest was Q1 2024, with a drop of 48.89 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -37.69% (Q1 2026), -31.79% (Q4 2025) and -27.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 LENZ Therapeutics 120.64 Mn 120.64 Mn 5.21 Mn -49.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.50%
Mar 31, 2026 -37.69%
Dec 31, 2025 -31.79%
Sep 30, 2025 -27.51%
Jun 30, 2025 -25.03%
Mar 31, 2025 -22.92%
Dec 31, 2024 -22.04%
Sep 30, 2024 -27.47%
Jun 30, 2024 -33.66%
Mar 31, 2024 -80.33%
Dec 31, 2023 -73.44%
Sep 30, 2023 -45.12%
Jun 30, 2023 -42.80%
Mar 31, 2023 -31.43%
Dec 31, 2022 -31.09%
Sep 30, 2022 -28.17%
Jun 30, 2022 -23.57%
Mar 31, 2022 -19.78%
Dec 31, 2021 -17.30%
Sep 30, 2021 -28.72%
API Access

LENZ Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LENZ&period=max&api_key=YOUR_API_KEY